Company: ZDAN
Filing Date: 2025-07-28
Form Type: F-1/A
Source: 0001683168-25-005450
Chunk: 126

Company: Zerolimit Technology Holding Co. Ltd.
Filing Date: 2025-07-28
Form: F-1/A
Chunk 126
---
by these cautionary statements. We disclaim any obligation to update our forward-looking statements, except as required by law.

Industry Data and Forecasts

This prospectus contains
data related to the VIE’s industry and market position in China and globally. This industry data includes projections that are based
on a number of assumptions that were derived from industry and government sources which we believe to be reasonable. The decentralized
distributed technology industry may not grow at the rate projected by industry data, or at all. The failure of the industry to grow as
anticipated is likely to have a material adverse effect on the VIE’s business and, accordingly, the market price of our Ordinary
Shares. In addition, the rapidly changing nature of the decentralized distributed technology industry subjects any projections or estimates
relating to the growth prospects or future condition of the VIE’s operations to significant uncertainties. Furthermore, if any one
or more of the assumptions underlying the industry data turns out to be incorrect, actual results may, and are likely to, differ from
the projections based on these assumptions.

| 67 |

<div align='center'>USE OF PROCEEDS</div>

We estimate that we will
receive net proceeds from this offering of approximately US$8 million, or approximately US$[*] million if the Underwriter exercises its
over-allotment option in full, after deducting underwriting discounts, non-accountable expense allowance and estimated offering expenses
payable by us. These estimates are based upon an assumed initial public offering price of US$4 per Ordinary Share.

We plan to use the net proceeds
of this offering (assuming no exercise of the over-allotment option) as follows in the order of priority:

| · | approximately 40%, or US$3 million for research and development;           |
| · | approximately 25%, or US$2 million for new product production;             |
| · | approximately 20%, or US$1.6 million for marketing and sales activities;   
 and                                                                        |
| · | approximately 15%, or the remaining amount for general corporate purposes, 
 which may include working capital needs and other corporate uses.          |

The amounts and timing of
any expenditures will vary depending on the amount of cash generated by our operations, and the rate of growth, if any, of our business,
and our plans and business conditions. The foregoing represents our intentions as of the date of this prospectus based upon our current
plans and business conditions to use and allocate the net proceeds of this offering.